Ofatumumab as Part of Reduced Intensity Conditioning in High Risk b-cell Lymphoma Patients: Results from a Prospective Multicenter Phase-II Trial

Autores de IIS La Fe

• Isidro Jarque Ramos

  Autor

• Jaime Sanz Caballer

  Autor

Participantes ajenos a IIS La Fe

• Cabrero, M
• Perez-Lopez, E
• de la Cruz-Vicente, F
• Martin-Lopez, AA
• Valcarcel, D
• Martin, A
• Espigado, I
• Orti, G
• Martin-Calvo, C
• Grande, C
• Lopez-Corral, L
• Caballero, D

Grupos

• Hematología y Hemoterapia

Abstract

Abstract no disponible